The Safety Challenge: Can We Trust Organ-on-Chip?
Source: Drug Discovery Online
Samantha explains the limitations of current NAMS for systemic toxicology and stresses context-of-use validation. Zaher counters with a provocative point: countless safe drugs were abandoned due to misleading animal toxicity results, calling for a paradigm shift away from reactionary policies rooted in outdated laws.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online